Search

Your search keyword '"Nervous system -- Care and treatment"' showing total 86 results

Search Constraints

Start Over You searched for: Descriptor "Nervous system -- Care and treatment" Remove constraint Descriptor: "Nervous system -- Care and treatment"
86 results on '"Nervous system -- Care and treatment"'

Search Results

51. A medical hypothesis: injection snoreplasty with B vitamins

52. Communication between median and musculocutaneous nerve and accessory head of biceps brachii: a case report

53. CAN JELLYFISH HELP FIGHT ALZHEIMER'S?

54. Going Out on a Limb

55. Stress, aging, and neurodegenerative disease

56. Neurodegeneration and aldehyde load: from concept to therapeutics

57. T cells for brain cells

58. Update on SCA3

59. Coenzyme [Q.sub.10] for neurodegenerative diseases

60. Defying gravity

61. A mind for progress

62. Domenici's leaving means a fifth open Senate seat

63. Helping nerves beat evolutionary costs

64. Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndrome

65. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns

68. Restoring neuron formation: neuroscience, in rodents, aminoprpylcarbazole also helps neurons survive

69. Antibodies aid nerve repair

70. Preventing memory loss: should we encourage use of scientific techniques to enhance memory and other cognitive functions?

71. Pediatric epilepsy surgery fails to aid later cognitive function

72. Ethics and stem cell testing

73. Stroke--arundic acid

74. Research and Markets Adds Report: Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

75. Adult stem cell breakthrough for neurodegenerative diseases reported

76. University of Toronto obtains United States patent

77. ExonHit raises additional 8.3M [euro]; now has cash to last into 2006

78. Xigen SA

79. Caspase Inhibitors Are Neuroprotective

80. Cambridge NeuroScience receives two United States patents and three United States patent allowances

82. The depth jump

83. Phytopharm plc

84. Faust Pharmaceuticals acquires Euroclide, seeks 12m [euro] funding

85. ExonHit Therapeutics SA, of Paris, began a phase I trial of EHT 0202, its small molecule being developed as a potential treatment for neurodegenerative disorders

86. Neuropharmaceutical market in USA

Catalog

Books, media, physical & digital resources